GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

Symbol: LTRN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$293,191	96,742	+4,661	+5.1%	$3.03	Q4 2025
30 Sep 2025	0%	0%	$400,647	92,081	+190	+0.21%	$4.35	Q3 2025
30 Jun 2025	0%	0%	$290,438	91,891	+1,387	+1.5%	$3.16	Q2 2025
31 Mar 2025	0%	+0%	$320,470	90,504	+3,531		$3.54	Q1 2025
31 Dec 2024	0%	0%	$277,521	86,973	-462	-0.53%	$3.19	Q4 2024
30 Sep 2024	0%	0%	$320,958	87,435	+1,088	+1.3%	$3.67	Q3 2024
30 Jun 2024	0%	0%	$403,336	86,347	-1,027	-1.2%	$4.67	Q2 2024
31 Mar 2024	0%	-0%	$769,065	87,374	-7,662	-8.1%	$8.80	Q1 2024
31 Dec 2023	0%	0%	$406,831	95,036	0		$4.28	Q4 2023
30 Sep 2023	0%	+0%	$324,141	95,036	+5,010	+5.6%	$3.41	Q3 2023
30 Jun 2023	0%	+0%	$507,746	90,026	+32,252	+56%	$5.64	Q2 2023
31 Mar 2023	0%	0%	$279,048	57,774	0		$4.83	Q1 2023
31 Dec 2022	0%	0%	$348,000	57,774	-135	-0.23%	$6.02	Q4 2022
30 Sep 2022	0%	0%	$276,000	57,909	+345	+0.6%	$4.77	Q3 2022
30 Jun 2022	0%	0%	$328,000	57,564	+521	+0.91%	$5.70	Q2 2022
31 Mar 2022	0%	0%	$407,000	57,043	0		$7.13	Q1 2022
31 Dec 2021	0%	0%	$455,000	57,043	0		$7.98	Q4 2021
30 Sep 2021	0%	+0%	$637,000	57,043	+1,564	+2.8%	$11.17	Q3 2021
30 Jun 2021	0%	+0%	$809,000	55,479	+9,649	+21%	$14.58	Q2 2021
31 Mar 2021	0%	+0%	$831,000	45,830	+45,830	NEW	$18.13	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.